A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema

Akgul A., Tarakci E., Arman N., Civi T., Irmak S.

LYMPHATIC RESEARCH AND BIOLOGY, cilt.18, ss.439-447, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1089/lrb.2019.0064
  • Dergi Adı: LYMPHATIC RESEARCH AND BIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.439-447
  • Anahtar Kelimeler: secondary lymphedema, platelet-rich plasma, low-level laser therapy, complex decongestive physiotherapy, QoL, MAST-CELLS, DEVICE, BLOOD, SKIN
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: Platelet-rich plasma (PRP) is an autologous concentrated preparation of platelets characterized by lymphangiogenetic and tissue-repairing effects. Although PRP has been safely used in many different fields, there is no clinical study regarding the use of PRP in lymphedema treatment in humans. We assessed the clinical outcomes of PRP in patients with lower extremity lymphedema (LEL) in a randomized controlled trial.